P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs

Journal of Ethnopharmacology

Volumn 141, Issue 2, 2012, Pages 557-570

  Eichhorn, Tolga ^a   Efferth, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cancer; Chemotherapy; Multidrug resistance; Pharmacognosy; Phytochemistry

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; BAICALEIN; BAICALIN; BERBERINE; CANADINE; CATECHIN; CHLOROGENIC ACID; COPTISINE; CRYPTOTANSHINONE; CURCUMIN; DAURICINE; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GINKGO BILOBA EXTRACT; GLABRIDIN; GLYCOPROTEIN P; GOMISIN; GOMISIN A; JATRORRHIZINE; KAEMPFEROL; MULTIDRUG RESISTANCE PROTEIN 1; PALMATINE; PLANT MEDICINAL PRODUCT; POLYPHENOL; QUERCETIN; TANSHINONE IIA; TETRANDRINE; UNINDEXED DRUG; XIAO CHAI HU TANG;

ALISMA ORIENTAL; ALISMA ORIENTALIS; ANGELICA SINENSIS; ANTRODIA CAMPHORATA; CAMELIA SINENSIS; CANCER INHIBITION; CANCER RESISTANCE; CAULIS MAHONIAE; CEPHALOTAXUS HARRINGTONIA; CHINESE HERB; COPTIS CHINENSIS; COPTIS JAPONICA; CURCUMA LONGA; ELEUTHEROCOCCUS SENTICOSUS; EVODIA RUAECARPA; GINKGO BILOBA; GINSENG; GLYCORRHIZA GLABRA; GLYCYRRHIZA INFLATA; HIPPOPHAE RHAMNOIDES; HUMAN; LIGUSTICUM CHUANXIONG; MARSDENIA TENACISSIMA; MULTIDRUG RESISTANCE; NONHUMAN; PAEONIA ALBA; PAEONIA LACTIFLORA; PEUCADANUM PRAERUPTORUM; PEUCEDANUM PRAERUPTORUM; PHELLODENDRON WILSONII; PINUS MASSONIANA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOLARIX KAEMPFERI; REVIEW; RHINACANTHUS NASUTUS; SALVIA MILTIORRHIZA; SCHISANDRA CHINENSIS; SCUTELLARIA BAICALENSIS; SINOMENIUM ACUTUM; SINOMONIUM ACUTUM; STEMONA TUBEROSA; STEPHANIA TETANDRA; TRITERYGUM WILFORDII;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG RESISTANCE, NEOPLASM; DRUGS, CHINESE HERBAL; HUMANS; NEOPLASMS; P-GLYCOPROTEIN; PLANTS, MEDICINAL;

EID: 84861186076     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2011.08.053     Document Type: Review

References (216)

1. P. Abidi, W. Chen, F.B. Kraemer, H. Li, and J. Liu The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms Journal of Lipid Research 47 2006 2134 2147
2. M. Adams, A. Mahringer, O. Kunert, G. Fricker, T. Efferth, and R. Bauer Cytotoxicity and p-glycoprotein modulating effects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa Planta Medica 73 2007 1554 1557
3. M. Adams, A. Mahringer, R. Bauer, G. Fricker, and T. Efferth In vitro cytotoxicity and P-glycoprotein modulating effects of geranylated furocoumarins from Tetradium daniellii Planta Medica 73 2007 1475 1478
4. M.M. Ameyaw, F. Regateiro, T. Li, X. Liu, M. Tariq, A. Mobarek, N. Thornton, G.O. Folayan, J. Githang'a, A. Indalo, D. Ofori-Adjei, D.A. Price-Evans, and H.L. McLeod MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity Pharmacogenetics 11 2001 217 221
5. C. Ampasavate, U. Sotanaphun, P. Phattanawasin, and N. Piyapolrungroj Effects of Curcuma spp. on P-glycoprotein function Phytomedicine 17 2010 506 512
6. A. Angelini, C. Di Ilio, M.L. Castellani, P. Conti, and F. Cuccurullo Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin-resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy Journal of Biological Regulators and Homeostatic Agents 24 2010 197 205
7. J.M. Aran, I. Pastan, and M.M. Gottesman Therapeutic strategies involving the multidrug resistance phenotype: the MDR1 gene as target, chemoprotectant, and selectable marker in gene therapy Advances in Pharmacology 46 1999 1 42
8. S. Ayesh, Y.M. Shao, and W.D. Stein Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein Biochimica et Biophysica Acta 1316 1996 8 18
9. M.R. Baer, S.L. George, and R.K. Dodge Phase 3 study of the multidrug-resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720 Blood 100 2002 1224 1232
10. T. Bansal, A. Awasthi, M. Jaggi, R.K. Khar, and S. Talegaonkar Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein Life Sciences 83 2008 250 259
11. J. Bertram, K. Palfner, M. Kielian, W. Brysch, K.H. Schlingensiepen, W. Hiddemann, and M. Kneba Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes Anti-Cancer Drugs 6 1995 124 134
12. P.J. Biermann, R.G. Bagin, S. Jagannath, J.M. Vose, G. Spitzer, A. Kessinger, K.A. Dicke, and J.O. Armitage High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients Annals of Oncology: Official Journal of the European Society of Medical Oncology/ESMO 4 1993 767 773
13. H. Bolhuis, H.W. van Veen, D. Molenaar, B. Poolman, A.J. Driessen, and W.N. Konings Multidrug resistance in Lactococcus lactis: evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane The EMBO Journal 15 1996 4239 4245
14. M.J. Borgnia, G.D. Eytan, and Y.G. Assaraf Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity Journal of Biological Chemistry 271 1996 3163 3171
15. D. Botstein, and N. Risch Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease Nature Genetics 33 Suppl. 2003 228 237
16. A. Calcabrini, A. Stringaro, L. Toccacieli, S. Meschini, M. Marra, M. Colone, G. Salvatore, F. Mondello, G. Arancia, and A. Molinari Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells The Journal of Investigative Dermatology 122 2004 349 360
17. J. Cao, X. Chen, J. Liang, X.Q. Yu, A.L. Xu, E. Chan, D. Wei, M. Huang, J.Y. Wen, X.Y. Yu, X.T. Li, F.S. Sheu, and S.F. Zhou Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra Drug Metabolism and Disposition 35 2007 539 553
18. C.S. Carlson, M.A. Eberle, M.J. Rieder, J.D. Smith, L. Kruglyak, and D.A. Nickerson Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome studies in humans Nature Genetics 33 2003 518 521
19. I.B. Carr Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats Cancer Research 47 1987 5577 5583
20. S. Chai, K.K.W. To, and L. Ge Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines Chinese Medicine 5 2010 26
21. H.S.L. Chan, G. Haddad, P.S. Thorner, G. DeBoer, Y.P. Lin, N. Ondrusek, H. Yeger, and V. Ling P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma The New England Journal of Medicine 325 1991 1608 1614
22. K. Chan, Z.Q. Liu, Z.H. Jiang, H. Zhou, Y.F. Wong, H.X. Xu, and L. Liu The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model Journal of Ethnopharmacology 103 2006 425 432
23. J.Y. Chang, C.Y. Chang, C.C. Kuo, L.T. Chen, Y.S. Wein, and Y.H. Kuo Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells Molecular Pharmacology 65 2004 77 84
24. C.J. Chen, J.E. Chin, K. Ueda, D.P. Clark, I. Pastan, M.M. Gottesman, and I.B. Roninson Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell 47 1986 381 389
25. H.Y. Chen, T.S. Wu, S.F. Su, S.C. Kuo, and P.D. Chao Marked decrease of cyclosporin absorption caused by phellamurin in rats Planta Medica 68 2002 138 141
26. Y. Chen, X. Wang, H. Sun, D. Xing, J. Hu, Z. Wai, and L. Du Characterization of the transportation of berberine in Coptidis rhizoma extract through rat primary cultured cortical neurons Biomedical Chromatography 22 2008 28 33
27. Y.W. Chen, G.J. Lin, Y.P. Chuang, W.T. Chia, D.Y. Hueng, C.K. Lin, S. Nieh, and H.K. Sytwu Triptolide circumvents drug-resistant effect and enhances 5-fluorouracil antitumor effect on KB cells Anticancer Drugs 21 2010 502 513
28. C.H. Choi, G. Kang, and Y.D. Min Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng Planta Medica 69 2003 235 240
29. K.H. Choi, C.J. Chen, M. Kriegler, and I.B. Roninson An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene Cell 53 1988 519 529
30. S.U. Choi, S.H. Park, K.H. Kim, E.J. Choi, S. Kim, W.K. Park, Y.H. Zhang, H.S. Kim, N.P. Jung, and C.O. Lee The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein Anticancer Drugs 9 1998 255 261
31. C. Cordon-Cardo, J.P. O'Brien, D. Casals, L. Rittman-Grauer, J.L. Biedler, M.R. Melamed, and J.R. Bertino Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proceedings of the National Academy of Sciences of the United States of America 86 1989 695 698
32. J.Y. Dai, J.L. Yang, and C. Li Transport and metabolism of flavonoids from Chinese herbal remedy Xiaochaihu-tang across human intestinal Caco-2 cell monolayers Acta Pharmacologica Sinica 29 2008 1086 1093
33. W.S. Dalton, J.J. Crowley, S.S. Salmon, T.M. Grogan, L.R. Laufman, G.R. Weiss, and J.D. Bonnet A phase II randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study Cancer 75 1995 815 820
34. Y. Dong, Y. Zhang, Q. Yang, Y. Li, and X. Zhu Absorption of extractive Radix Paeoniae Alba in rat everted gut sacs and its interaction with P-glycoprotein Zhongguo Zhong Yao Za Zhi 34 2009 884 888 (article in Chinese)
35. Y. Dönmez, and U. Gündüz Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells Biomedicine and Pharmacotherapy 65 2011 85 89
36. H.G Eckert, M. Stockschlager, U. Just, S. Hegewisch-Becker, M. Grez, A. Uhde, A. Zander, W. Ostertag, and C. Baum High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors Blood 88 1996 3407 3415
37. T. Efferth, M. Davey, A. Olbrich, G. Rücker, E. Gebhart, and R. Davey Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells Blood Cells, Molecules and Diseases 28 2002 160 168
38. T. Efferth, T.A. Dunn, M. Berlion, H. Langenbahn, E.W. Pommerenke, and M. Volm Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788 Anticancer Research 13 1993 905 908
39. T. Efferth, U. Fabry, and R. Osieka Anti-Fas/Apo-1 monoclonal antibody CH-11 depletes glutathione and kills multidrug-resistant human leukemic cells Blood Cells, Molecules and Diseases 22 1996 2 9
40. T. Efferth, Y.J. Fu, Y.G. Zu, G. Schwarz, V.S. Konkimalla, and M. Wink Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine Current Medicinal Chemistry 14 2007 2024 2032
41. T. Efferth, B.W. Futscher, and R. Osieka 5-Azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs Blood Cells, Molecules and Diseases 27 2001 637 648
42. T. Efferth, and R. Grassmann Impact of viral oncogenesis on responses to anti-cancer drugs and irradiation Critical Reviews in Oncogenesis 11 2000 165 187
43. T. Efferth, S. Kahl, K. Paulus, M. Adams, R. Rauh, H. Boechzelt, X. Hao, B. Kaina, and R. Bauer Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese materia medica with activity against tumor cells Molecular Cancer Therapeutics 7 2008 152 161
44. T. Efferth, T. Klett, J. Mattern, H. Osswald, E.W. Pommerenke, M. Stöhr, and M. Volm Reversing multidrug resistance in L1210 tumor cells by hycanthone or chlorophenoxamine in vitro and in vivo Anticancer Research 11 1991 1275 1279
45. T. Efferth, V.B. Konkimalla, Y.F. Wang, A. Sauerbrey, S. Meinhardt, F. Zintl, J. Mattern, and M. Volm Prediction of broad spectrum resistance of tumors towards anticancer drugs Clinical Cancer Research 14 2008 2405 2412
46. T. Efferth, B. Lathan, and M. Volm Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4 British Journal of Cancer 64 1991 87 89
47. T. Efferth, P.C. Li, V.S. Konkimalla, and B. Kaina From traditional Chinese medicine to rational cancer therapy Trends in Molecular Medicine 13 2007 353 361
48. T. Efferth, J. Mattern, and M. Volm Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors Oncology 49 1992 368 375
49. T. Efferth, H. Miyachi, and H. Bartsch Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy Cancer Genomics and Proteomics 4 2007 81 91
50. T. Efferth, and R.R. Osieka Clinical relevance of the MDR-1 gene and its gene-product. P-glycoprotein, for cancer chemotherapy: a meta-analysis Tumordiagnostik und Therapie 14 1993 238 243
51. T. Efferth, A. Sauerbrey, D. Steinbach, E. Gebhart, H.G. Drexler, H. Miyachi, C.R. Chitambar, C.M. Becker, F. Zintl, and A. Humeny Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia International Journal of Oncology 23 2003 509 517
52. T. Efferth, and M. Volm Antibody-directed therapy of multidrug-resistant tumor cells Medical Oncology and Tumor Pharmacotherapy 9 1992 11 19
53. T. Efferth, and M. Volm Modulation of P-glycoprotein-mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells Oncology 50 1993 303 308
54. T. Efferth, and M. Volm Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms Cancer Letters 70 1993 197 202
55. T. Efferth, and M. Volm Pharmacogenetics for individualized cancer chemotherapy Pharmacology and Therapeutics 107 2005 155 176
56. M. Eichelbaum, M.F. Fromm, and M. Schwab Clinical aspects of the MDR1 (ABCB1) gene polymorphism Therapeutic Drug Monitoring 26 2004 180 185
57. N. Eswar, M.A. Marti-Renom, B. Webb, M.S. Madhusudhan, D. Eramian, M. Shen, U. Pieper, and A. Sali Comparative protein structure modeling with MODELLER Current Protocols in Bioinformatics, Supplement 15 2006 John Wiley & Sons, Inc. pp. 5.6.1-5.6.30
58. W.E. Evans, and M.V. Relling Pharmacogenomics: translating functional genomics into rational therapeutics Science 286 1999 487 491
59. C.R. Fairchild, S.P. Ivy, T. Rushmore, G. Lee, P. Koo, M. Goldsmith, C.E. Myers, E. Farber, and K.H. Cowan Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas Proceedings of the National Academy of Sciences of the United States of America 84 1987 7701 7705
60. L. Fan, X.Q. Mao, G.Y. Tao, G. Wang, F. Jiang, Y. Chen, Q. Li, W. Zhang, H.P. Lei, D.L. Hu, Y.F. Huang, D. Wang, and H.H. Zhou Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers Xenobiotica 39 2009 249 254
61. L. Fan, G.Y. Tao, G. Wang, Y. Chen, W. Zhang, Y.J. He, Q. Li, H.P. Lei, F. Jiang, D.L. Hu, Y.F. Huang, and H.H. Zhou Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers The Annals of Pharmacotherapy 43 2009 944 949
62. F. Farabegoli, A. Papi, G. Bartolini, R. Ostan, and M. Orlandi (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line Phytomedicine 17 2010 356 362
63. S. Fellner, B. Bauer, D.S. Miller, M. Schaffrik, M. Fankhanel, T. Spruss, G. Bernhardt, C. Graeff, L. Farber, H. Gschaidmeier, A. Buschauer, and G. Fricker Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo Journal of Clinical Investigation 110 2002 1309 1318
64. V. Fischer, A. Rodriguez-Gascon, F. Heitz, R. Tynes, C. Hauck, D. Cohen, and A.E. Vickers The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite Drug Metabolism and Disposition 26 1998 802 811
65. D.J. FitzGerald, M.C. Willingham, C.O. Cardarelli, H. Hamada, T. Tsuruo, M.M. Gottesman, and I. Pastan A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells Proceedings of the National Academy of Sciences of the United States of America 84 1987 4288 4292
66. A.T. Fojo, K. Uda, D.J. Slamon, D.G. Poplack, M.M. Gottesman, and I. Pastan Expression of a multidrug-resistance gene in human tumors and tissues Proceedings of the National Academy of Sciences of the United States of America 84 1987 265 269
67. W.F. Fong, C.K. Wan, G.Y. Zhu, A. Chattopadhyay, S. Dey, Z. Zhao, and X.L. Shen Schisandrol A from Schisandra chinensis reverses P-glycoprotein- mediated multidrug resistance by affecting Pgp-substrate complexes Planta Medica 73 2007 212 220
68. W.F. Fong, C. Wang, G.Y. Zhu, C.H. Leung, M.S. Yang, and H.Y. Cheung Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract Phytomedicine 14 2007 160 165
69. J.M. Ford, and W.N. Hait Pharmacologic circumvention of multidrug resistance Cytotechnology 12 1993 171 212
70. J.M. Ford, J.M. Yang, and W.N. Hait P-Glycoprotein-mediated multidrug resistance: experimental and clinical strategies for its reversal Cancer Treatment and Research 87 1996 3 38
71. P.M. Fracasso, L.J. Goldstein, D.P. de Alwis, J.S. Rader, M.A. Arquette, S.A. Goodner, L.P. Wright, C.L. Fears, R.J. Gazak, V.A. Andre, M.F. Burgess, C.A. Slapak, and J.H. Schellens Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies Clinical Cancer Research 10 2004 7220 7228
72. L.W. Fu, L.R. He, Y.J. Liang, L.M. Chen, H.Y. Xiong, X.P. Yang, and Q.C. Pan Experimental chemotherapy against xenografts derived from multidrug resistant KBv200 cells and parental drug-sensitive KB cells in nude mice by annonaceous acetogenin 89-2 Yao Xue Xue Bao 38 2003 565 570
73. N. Gao, Y. Zhang, J.Q. Mao, G.Q. Li, W. Zhou, B. Gao, and J. Gu Effects of some traditional Chinese drugs on Mdr1 gene and its expression product in K562/A02 cells Zhongguo Shi Yan Xue Ye Xue Za Zhi 16 2008 785 789 (article in Chinese)
74. J. Geng, and D. Zhou Coriaria lactone induces in vitro the overexpression of multidrug resistance P-glycoprotein in astrocyte from rat brain Sichuan Da Xue Xue Bao Yi Xue Ban 39 2008 80 83 (article in Chinese)
75. U.A. Germann P-glycoprotein - a mediator of multidrug resistance in tumour cells European Journal of Cancer 32A 1996 927 944
76. J.P. Gillet, T. Efferth, and J. Remacle Chemotherapy-induced resistance by ATP-binding cassette transporter genes Biochimica and Biophysica Acta Review Cancer 1775 2007 237 262
77. C. Globisch, I.K. Pajeva, and M. Wiese Identification of putative binding sites of P-glycoprotein based on its homology model Chemical Medicinal Chemistry 3 2008 280 295
78. B.C. Goh, S.C. Lee, L.Z. Wang, L. Fan, J.Y. Guo, J. Lamba, E. Schuetz, R. Lim, H.L. Lim, A.B. Ong, and H.S. Lee Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies Journal of Clinical Oncology 20 2002 3683 3690
79. A. Gotoh, T. Sakaeda, T. Kimura, T. Shirakawa, Y. Wada, A. Wada, T. Kimachi, Y. Takemoto, A. Iida, S. Iwakawa, M. Hirai, H. Tomita, N. Okamura, T. Nakamura, and K. Okumura Antiproliferative activity of Rhinacanthus nasutus (L.) Kurz extracts and the active moiety, Rhinacanthin C Biological & Pharmaceutical Bulletin 27 2004 1070 1074
80. M.M. Gottesman, C.A. Hrycyna, P.V. Schoenlein, U.A. German, and I. Pastan Genetic analysis of the multidrug transporter Annual Review of Genetics 29 1995 607 649
81. M.M. Gottesman, and I. Pastan Biochemistry of multidrug resistance mediated by the multidrug transporter Annual Review of Biochemistry 62 1993 385 427
82. Y. Gu, G. Wang, G. Pan, J.P.A.J. Fawcett, and J. Sun Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali Basic and Clinical Pharmacology and Toxicology 95 2004 295 298
83. M.D Hall, M.D. Handley, and M.M. Gottesman Is resistance useless? Multidrug resistance and collateral sensitivity Trends in Pharmacological Sciences 30 2009 546 556
84. L. He, and G.Q. Liu Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells Acta Pharmacologica Sinica 23 2002 591 596
85. L. He, J. Yang, and L. Hu Transmembrane transport activity of paclitaxel regulated by fangchinoline in MDR1-mDCK II cells Zhongguo Zhong Yao Za Zhi 35 2010 1478 1481 (article in Chinese)
86. L. He, C. Zhao, M. Yan, L.Y. Zhang, and Y.Z. Xia Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier Phytotherapy Research 23 2009 933 937
87. C.F. Higgins, and M.M. Gottesman Is the multidrug transporter a flippase? Trends in Biochemical Sciences 17 1992 18 21
88. B.T. Hill, K. Deuchars, L.K. Hosking, V. Ling, and R.D.H. Whelan Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro Journal of the National Cancer Institute 82 1990 607 612
89. S.P. Ho, D.H. Britton, B.A. Stone, D.L. Behrens, L.M. Leffet, F.W. Hobbs, J.A. Miller, and G.L. Trainor Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries Nucleic Acids Research 24 1996 1901 1907
90. S. Hoffmeyer, O. Burk, O. von Richter, H.P. Arnold, J. Brockmöller, A. Johne, I. Cascorbi, T. Gerloff, I. Roots, M. Eichelbaum, and U. Brinkmann Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo Proceedings of the National Academy of Sciences of the United States of America 97 2000 3473 3478
91. J.K. Holland, O. Glidewell, and R.G. Cooper Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast Surgery Gynecology and Obstetrics 150 1980 817 821
92. P.S. Holm, K.J. Scanlon, and M. Dietel Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme British Journal of Cancer 70 1994 239 243
93. J.A. Holmes, and R.R. West The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia British Journal of Cancer 69 1994 382 384
94. T. Honda, Y. Dan, N. Koyabu, I. Ieiri, K. Otsubo, S. Higuchi, H. Ohtani, and Y. Sawada Polymorphism of MDR1 gene in healthy Japanese subjects: a novel SNP with an amino acid substitution (Glu108Lys) Drug Metabolism and Pharmacokinetics 17 2002 479 481
95. Y.J. Hu, X.L. Shen, H.L. Lu, Y.H. Zhang, X.A. Huang, L.C. Fu, and W.F. Fong Tenacigenin B derivatives reverse P-glycoprotein-mediated multidrug resistance inHepG2/Dox cells Journal of Natural Products 71 2008 1049 1051
96. B.B. Huang, G.F. Li, F. Ren, Z.K. Tang, H.F. Ma, Y.B. Sun, L.J. Chen, and L. Yang Effect of Glycyrrhiza inflata and Daphne genkwa on permeabilities of rhodamine 123, a P-glycoprotein substrate across rat jejunum membranes in vitro Zhongguo Zhong Yao Za Zhi 33 2008 2521 2526 (article in Chinese)
97. M. Huang, J. Jin, H. Sun, and G.T. Liu Reversal of P-glycoprotein- mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae Cancer Chemotherapy and Pharmacology 62 2008 1015 1026
98. Y. Huang, G. Dong, X. Hong, H. Chai, and X. Yuan Studies on reversing MDR of K562/A02 by ramification of curcumin hydrolyzed Zhongguo Zhong Yao Za Zhi 35 2010 2460 2463 (article in Chinese)
99. A. Humeny, F. Rödel, C. Rödel, R. Sauer, L. Füzesi, C. Becker, and T. Efferth MDR1 single nucleotide polymorphism C3435T in normal colorectal tissue and colorectal carcinomas detected by MALDI-TOF mass spectrometry Anticancer Research 23 2003 2735 2740
100. T. Illmer, U.S. Schuler, C. Thiede, U.I. Schwarz, R.B. Kim, S. Gotthard, D. Freund, U. Schäkel, G. Ehninger, and M. Schaich MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients Cancer Research 62 2002 4955 4962
101. R.L. Juliano, and V. Ling A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants Biochimica and Biophysica Acta 455 1976 152 162
102. D. Kamp, and C.W. Haest Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane Biochimica et Biophysica Acta 1372 1998 91 101
103. W.N. Keith, and R. Brown Carcinogenesis and the response of tumours to anticancer drugs Anticancer Research 11 1991 1739 1743
104. R.B. Kim MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences Pharmacogenetics 12 2002 425 427
105. R.B. Kim, M.F. Fromm, C. Wandel, B. Leake, A.J. Wood, D.M. Roden, and G.R. Wilkinson The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors Journal of Clinical Investigation 101 1998 289 294
106. S. Kitagawa, T. Nabekura, and S. Kamiyama Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells The Journal of Pharmacy and Pharmacology 56 2004 1001 1005
107. C.M. Kruijtzer, J.H. Beijnen, H. Rosing, W.W. ten Bokkel Huinink, M. Schot, R.C. Jewell, E.M. Paul, and J.H. Schellens Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918 Journal of Clinical Oncology 20 2002 2943 2950
108. Y. Kurata, I. Ieiri, M. Kimura, T. Morita, S. Irie, A. Urae, S. Ohdo, H. Ohtani, Y. Sawada, S. Higuchi, and K. Otsubo Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein Clinical Pharmacology and Therapeutics 72 2002 209 219
109. K. Lan, J.L. He, Y. Tian, F. Tan, X.H. Jiang, L. Wang, and L.M. Ye Intra-herb pharmacokinetics interaction between quercetin and isorhamentin Acta Pharmacologica Sinica 29 2008 1376 1382
110. M.J. LeBlanc, S. Brunet, G. Bouchard, T. Lamireau, I.M. Yousef, V. Gavino, E. Lévy, and B. Tuchweber Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats The Journal of Nutritional Biochemistry 14 2003 40 48
111. C.G. Lee, M.M. Gottesman, C.O. Cardarelli, M. Ramachandra, K.T. Jeang, S.V. Ambudkar, I. Pastan, and S. Dey HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter Biochemistry 37 1998 3594 3601
112. Y. Lee, H. Yeo, S.H. Liu, Z. Jiang, R.M. Savizky, D.J. Austin, and Y.C. Cheng Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring Journal of Medicinal Chemistry 47 2004 5555 5566
113. P.H. Leung, L. Zhang, Z. Zuo, and G. Lin Intestinal absorption of Stemona alkaloids in a Caco-2 cell model Planta Medica 72 2006 211 216
114. G.H. Li, M.X. Liu, F.J. Sun, N. Wang, G.P. Yin, X.J. Li, and W.F. Li The effect of tetrandrine on the expression of the P170, LRP and TOPO II in S180s tumor cell induced by chemotherapy in the mice with acquired multi-drug resistance Zhongguo Zhong Yao Za Zhi 30 2005 1280 1282 (article in Chinese)
115. G.H. Li, F.J. Sun, F. Chen, S.B. Yang, and J. Zhang Effect on mouse S180 MDR tumour cell expression correlated factorial matter by 70% ethanol with Huanglian Jiedu Tang Zhongguo Zhong Yao Za Zhi 32 2007 1906 1908 (article in Chinese)
116. L. Li, J.D. Stanton, A.H. Tolson, Y. Luo, and H. Wang Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways Pharmaceutical Research 26 2009 872 882
117. S.L. Li, Z.N. Huang, H.H. Hsieh, W.C. Yu, W.Y. Tzeng, G.Y. Lee, Y.P. Chen, C.Y. Chang, and J.J. Chuu The augmented anti-tumor effects of Antrodia camphorata co-fermented with Chinese medicinal herb in human hepatoma cells The American Journal of Chinese Medicine 37 2009 771 783
118. Y. Li, Q. Wang, X. Yao, and Y. Li Induction of CYP3A4 and MDR1 gene expression by baicalin, baicalein, chlorogenic acid, and ginsenoside Rf through constitutive androstane receptor- and pregnane X receptor-mediated pathways European Journal of Pharmacology 640 2010 46 54
119. G. Liang, A. Tang, X. Lin, L. Li, S. Zhang, Z. Huang, H. Tang, and Q.Q. Li Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer International Journal of Oncology 37 2010 111 123
120. H.L. Lin, T.Y. Liu, W.Y. Lui, and C.W. Chi Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells Cancer 85 1999 1937 1942
121. H.L. Lin, T.Y. Liu, C.W. Wu, and C.W. Chi Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel British Journal of Cancer 81 1999 416 422
122. V.L. Madgula, B. Avula, Y.W. Choi, S.V. Pullela, I.A. Khan, L.A. Walker, and S.I. Khan Transport of Schisandra chinensis extract and its biologically-active constituents across Caco-2 cell monolayers - an in-vitro model of intestinal transport Journal of Pharmaceutical Pharmacology 60 2008 363 370
123. A. Mahringer, S. Karamustafa, D. Klotz, S. Kahl, V.B. Konkimala, Y.F. Wang, J.S. Wang, H.-Y. Liu, H. Boechzelt, X.J. Hao, R. Bauer, G. Fricker, and T. Efferth Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine Cancer Genomics Proteomics 7 2010 191 206
124. S. Majumder, P. Dutta, P. Mukherjee, E.R. Datta, T. Efferth, S. Bhattacharya, and S.K. Choudhuri Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid Cancer Letters 244 2006 16 23
125. Y. Mei, F. Qian, D. Wei, and J. Liu Reversal of cancer multidrug resistance by green tea polyphenols The Journal of Pharmacy and Pharmacology 56 2004 1307 1314
126. L.A. Mickley, B.A. Spengler, T.A. Knutsen, J.L. Biedler, and A.T. Fojo Gene rearrangement: a novel mechanism for MDR-1 gene activation The Journal of Clinical Investigation 99 1997 1947 1957
127. Y.D. Min, M.C. Yang, K.H. Lee, K.R. Kim, S.U. Choi, and K.R. Lee Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome of Coptis japonica Makino Archives of Pharmacal Research 29 2006 757 761
128. J. Molnár, H. Engi, J. Hohmann, P. Molnár, J. Deli, O. Wesolowska, K. Michalak, and Q. Wang Reversal of multidrug resistance by natural substances from plants Current Topics in Medicinal Chemistry 10 2010 1757 1768
129. R. Mukai, H. Satsu, M. Shimizu, and H. Ashida Inhibition of P-glycoprotein enhances the suppressive effect of kaempferol on transformation of the aryl hydrocarbon receptor Bioscience, Biotechnology, and Biochemistry 73 2009 1635 1639
130. M. Nakayama, M. Wada, T. Harada, J. Nagayama, H. Kusaba, K. Ohsima, M. Kozuru, H. Komatsu, R. Ueda, and M. Kuwano Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias Blood 92 1998 4296 4307
131. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the last 25 years Journal of Natural Products 70 2007 461 477
132. N. Nishimura Effects of Chinese herbal medicines on intestinal drug absorption Yakugaku Zasshi 125 2005 363 369 (article in Japanese)
133. S. Nobili, I. Landini, B. Giglioni, and E. Mini Pharmacological strategies for overcoming multidrug resistance Current Drug Targets 7 2006 861 879
134. M. Osmak, and S. Perovic Multiple fractions of gamma rays induced resistance to cis-dichloro-diammineplatinum (II) and methotrexate in human HeLa cells International Journal of Oncology, Biology, Physics 16 1989 1537 1541
135. S.L. Plasschaert, E. Groninger, M. Boezen, I. Kema, E.G. de Vries, D. Uges, A.J. Veerman, W.A. Kamps, E. Vellenga, S.S. de Graaf, and E.S. de Bont Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia Clinical Pharmacology and Therapeutics 76 2004 220 229
136. S. Podda, M. Ward, A. Himelstein, C. Richardson, E. de la Flor-Weiss, L. Smith, M.M. Gottesman, I. Pastan, and A. Bank Transfer and expression of the human multiple drug resistance gene into live mice Proceedings of the National Academy of Sciences of the United States of America 89 1992 9676 9680
137. X.L. Qin, H.C. Bi, X.D. Wang, J.L. Li, Y. Wang, X.P. Xue, X. Chen, C.X. Wang, J. Xu le, Y.T. Wang, and M. Huang Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506) International Journal of Pharmaceutics 389 2010 114 121
138. W. Qiu, X.H. Jiang, C.X. Liu, Y. Ju, and J.X. Jin Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp Phytotherapy Research 23 2009 1553 1558
139. A. Ramu, H.B. Pollard, and L.M. Rosario Doxorubicin resistance in P388 leukemia - evidence for reduced drug influx International Journal of Cancer 44 1989 539 547
140. J. Rautio, J.E. Humphreys, and L.O. Webster In vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates Drug Metabolism and Disposition 34 2006 786 792
141. Y. Raviv, H.B. Pollard, E.P. Brüggemann, I. Pastan, and M.M. Gottesman Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells The Journal of Biological Chemistry 265 1990 3975 3980
142. C.P. Rhoads Report on a cooperative study of nitrogen mustard (HN2) therapy of neoplastic disease Transactions of the Association of American Physicians 60 1947 110 117
143. N. Risch The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches Cancer Epidemiology, Biomarkers and Prevention 10 2001 733 741
144. P.D. Roepe The role of the MDR protein in altered drug translocation across tumor cell membranes Biochimica et Biophysica Acta 1241 1995 385 406
145. I.B. Roninson, J.E. Chin, K. Choi, P. Gros, D.E. Housman, A. Fojo, D. Shen, M.M. Gottesman, and I. Pastan Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells Proceedings of the National Academy of Sciences of the United States of America 83 1986 4538 4542
146. S. Ruetz, and P. Gros A mechanism for P-glycoprotein action in multidrug resistance: are we there yet? Trends in Pharmacological Sciences 15 1994 260 263
147. J.C. Ruiz, K. Choi, D.D. von Hoff, I.B. Roninson, and G.M. Wahl Autonomously replicating episomes contain mdr1 genes in a multidrug-resistant human cell line Molecular Cell Biology 9 1989 109 115
148. R. Sachidanandam, D. Weissman, S.C. Schmidt, J.M. Kakol, L.D. Stein, G. Marth, S. Sherry, J.C. Mullikin, B.J. Mortimore, D.L. Willey, S.E. Hunt, C.G. Cole, P.C. Coggill, C.M. Rice, Z. Ning, J. Rogers, D.R. Bentley, P.Y. Kwok, E.R. Mardis, R.T. Yeh, B. Schultz, L. Cook, R. Davenport, M. Dante, L. Fulton, L. Hillier, R.H. Waterston, J.D. McPherson, B. Gilman, S. Schaffner, W.J. Van Etten, D. Reich, J. Higgins, M.J. Daly, B. Blumenstiel, J. Baldwin, N. Stange-Thomann, M.C. Zody, L. Linton, E.S. Lander, D. Altshuler, and International SNP Map Working Group A map of human genome sequence variations 1.42 million single nucleotide polymorphisms Nature 409 2001 928 933
149. A.R. Safa Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators Current Medicinal Chemistry Anticancer Agents 4 2004 1 17
150. T. Sakaeda, T. Nakamura, M. Horinouchi, M. Kakumoto, N. Ohmoto, T. Sakai, Y. Morita, T. Tamura, N. Aoyama, M. Hirai, M. Kasuga, and K. Okumura MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects Pharmaceutical Research 18 2001 1400 1404
151. T. Sakaeda, T. Nakamura, and K. Okumura Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs Pharmacogenomics 4 2003 397 410
152. A. Sauerbrey, F. Zintl, and M. Volm P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia British Journal of Cancer 70 1994 1144 1149
153. B. Scaggiante, C. Morassutti, G. Tolazzi, A. Michelutti, M. Baccarani, and F. Quandrifoglio Effect of unmodified triple helix-forming oligodeoxyribonucleotide targeted to human multidrug-resistance gene mdr1 in MDR cancer cells FEBS Letters 352 1994 380 384
154. A.H. Schinkel, and J.W. Jonker Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview Advanced Drug Delivery Reviews 55 2003 3 29
155. A.H. Schinkel, U. Mayer, E. Wagenaar, C.A.A.M. Mol, and L. van Deemter Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins Proceedings of the National Academy of Sciences of the United States of America 94 1997 4028 4032
156. A.H. Schinkel, J.J. Smith, O. van Tellingen, J.H. Beijnen, E. Wagenaar, L. van Deemter, C.A. Mol, M.A. van der Valk, E.C. Robanus-Maandag, and H.P. te Riele Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs Cell 77 1994 491 502
157. A.H. Schinkel, E. Wagenaar, C.A. Mol, and L. van Deemter P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs The Journal of Clinical Investigation 97 1996 2517 2524
158. J. Schneider, M. Bak, T. Efferth, M. Kaufmann, J. Mattern, and M. Volm P-glycoprotein expression in treated and untreated human breast cancer British Journal of Cancer 60 1989 815 818
159. M. Schwab, M. Eichelbaum, and M.F. Fromm Genetic polymorphisms of the human MDR1 drug transporter Annual Review of Pharmacology and Toxicology 43 2003 285 307
160. A. Seelig A general pattern for substrate recognition by P-glycoprotein European Journal of Biochemistry 251 1998 252 261
161. A. Seelig, and E. Landwojtowicz Structure-activity relationship of P-glycoprotein substrates and modifiers European Journal of Pharmacological Sciences 12 2000 31 40
162. A.B. Shapiro, and V. Ling Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein European Journal of Biochemistry 250 1997 122 129
163. A.B. Shapiro, and V. Ling The mechanism of ATP-dependent multidrug transport by P-glycoprotein Acta Physiologica Scandinavica 643 163 Suppl. 1998 227 234
164. H. Shen, W. Xu, Q. Chen, Z. Wu, H. Tang, and F. Wang Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription Journal of Cancer Research and Clinical Oncology 136 2010 659 665
165. X. Shen, G. Chen, G. Zhu, and W.F. Fong (+/-)-3′-O, 4′-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells Bioorganic and Medicinal Chemistry 14 2006 7138 7145
166. B.I Sikic Modulation of multidrug resistance: at the threshold Journal of Clinical Oncology 11 1993 1629 1635
167. M.D. Sklar Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes Cancer Research 48 1988 793 797
168. M.L. Slovak, G.A. Hoeltge, and J.M. Trent Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations Cancer Research 47 1987 6646 6652
169. J.J.M. Smit, A.H. Schinkel, R.P.J. Oude Elferink, A.K. Grown, E. Wagenaar, L. van Deemter, C.A. Mol, R. Ottenhoff, N.M. van der Lugt, and M.A. van Roon Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease Cell 75 1993 451 462
170. B.P. Sorrentino, S.J. Brandt, D. Bodine, M.M. Gottesman, I. Pastan, A. Cline, and A.W. Nienhuis Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1 Science 257 1992 99 103
171. B.P. Sorrentino, K.T. Mc Donagh, D. Woods, and D. Orlic Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice Blood 86 1995 491 501
172. H. Suzuki, H. Tanabe, H. Mizukami, and M. Inoue Selective regulation of multidrug resistance protein in vascular smooth muscle cells by the isoquinoline alkaloid coptisine Biological & Pharmaceutical Bulletin 33 2010 677 682
173. T. Takahashi, T. Kaku, T. Sato, K. Watanabe, and J. Sato Effects of Acanthopanax senticosus HARMS extract on drug transport in human intestinal cell line Caco-2 Journal of Natural Medicines 64 2010 55 62
174. K. Takara, T. Sakaeda, and K. Okumura An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy Current Pharmaceutical Design 12 2006 273 286
175. A.K. Tiwari, K. Sodani, C.L. Dai, C.R. Ashby Jr., and Z.S. Chen Revisiting the ABCs of multidrug resistance in cancer chemotherapy Current Pharmaceutical Biotechnology 12 2011 570 594
176. B.J. Trock, F. Leonessa, and R. Clarke Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance Journal of the National Cancer Institute 89 1997 917 931
177. P.L. Tsai, and T.H. Tsai Hepatobiliary excretion of berberine Drug Metabolism and Disposition 32 2004 405 412
178. P.L. Tsai, and T.H. Tsai Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study Planta Medica 70 2004 1069 1074
179. T.H. Tsai, and J.W. Wu Regulation of hepatobiliary excretion of sinomenine by P-glycoprotein in Sprague-Dawley rats Life Sciences 72 2003 2413 2426
180. T. Tsuruo, H. Hamada, S. Sato, and Y. Heike Inhibition of multidrug-resistant human tumor growth in athymic mice by anti-P-glycoprotein monoclonal antibodies Japanese Journal of Cancer Research: Gann 80 1989 627 631
181. J.B. Vaidyanathan, and T. Walle Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2 Journal of Pharmacology and Experimental Therapeutics 307 2003 745 752
182. A. van Helvoort, A.J. Smith, H. Sprong, I. Fritzsche, A.H. Schinkel, P. Borst, and G. van Meer MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine Cell 87 1996 507 517
183. P. Verrelle, F. Meissonnier, Y. Fonck, V. Feillel, C. Dionet, Kwiatkowski, R. Plagne, and J. Chassagne Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma Journal of the National Cancer Institute 83 1991 111 116
184. F. Vogel Moderne Probleme der Humangenetik Ergebnisse Innere Medizin Kinderheilkunde 12 1959 52 125
185. M. Volm, M. Kästel, J. Mattern, and T. Efferth Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas Cancer 71 1993 3981 3987
186. M. Volm, R. Koomägi, and T. Efferth Prediction of drug sensitivity and resistance of cancer by protein expression profiling Cancer Genomics and Proteomics 1 2004 157 166
187. M. Volm, R. Koomägi, J. Mattern, and T. Efferth Protein expression profiles indicative for drug resistance of non-small cell lung cancer British Journal of Cancer 87 2002 251 257
188. M. Volm, E.W. Wagner-Pommerenke, T. Efferth, H. Löhrke, and J. Mattern Circumvention of multi-drug resistance in human kidney and kidney carcinoma in vitro Cancer 67 1991 2484 2489
189. M. Volm, H. Zerban, J. Mattern, and T. Efferth Overexpression of P-glycoprotein in rat hepatocellular carcinomas induced with N-nitrosomorpholine Carcinogenesis 11 1990 169 172
190. C.K. Wan, G.Y. Zhu, X.L. Shen, A. Chattopadhyay, S. Dey, and W.F. Fong Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells Biochemical Pharmacology 72 2006 824 837
191. C. Wang, J.X. Zhang, X.L. Shen, C.K. Wan, A.K. Tse, and W.F. Fong Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetate Biochemical Pharmacology 68 2004 843 855
192. E.J. Wang, M. Barecki-Roach, and W.W. Johnson Elevation of P-glycoprotein function by a catechin in green tea Biochemical and Biophysical Research Communications 297 2002 412 418
193. J. Wang, Y. Xia, H. Wang, and Z. Hou Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901 Integrative Cancer Therapies 6 2007 400 404
194. T.X. Wang, and X.H. Yang Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells Yao Xue Xue Bao 43 2008 461 466
195. X.B. Wang, S.S. Wang, Q.F. Zhang, M. Liu, H.L. Li, Y. Liu, J.N. Wang, F. Zheng, L.Y. Guo, and J.Z. Xiang Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells Oncology Reports 23 2010 211 215
196. V.K. Wong, P. Chiu, S.S. Chung, L.M. Chow, Y.Z. Zhao, B.B. Yang, and B.C. Ko Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo Clinical Cancer Research 11 2005 6002 6011
197. J.Y. Wu, W.F. Fong, J.X. Zhang, C.H. Leung, H.L. Kwong, M.S. Yang, D. Li, and H.Y. Cheung Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani European Journal of Pharmacology 473 2003 9 17
198. Y.T. Wu, C.W. Lin, L.C. Lin, A.W. Chiu, K.K. Chen, and T.H. Tsai Analysis of biliary excretion of icariin in rats Journal of Agricultural and Food Chemistry 58 2010 9905 9911
199. D. Xu, Q. Lu, and X. Hu Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol Cancer Letters 243 2006 274 280
200. C.Y. Yang, P.D. Chao, Y.C. Hou, S.Y. Tsai, K.C. Wen, and S.L. Hsiu Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats Food and Chemical Toxicology 44 2008 1572 1578
201. H.W Yao, X.Y. Fu, Q.D. Xie, B.B. Huang, Y.B. Sun, and G.F. Li Effect of liquorice decoction on rat intestinal P-glycoprotein Nan Fang Yi Ke Da Xue Xue Bao 29 2009 1571 1573 (article in Chinese)
202. E.Y. Yeung, T. Sueyoshi, M. Negishi, and T.K. Chang Identification of Ginkgo biloba as a novel activator of pregnane X receptor Drug Metabolism and Disposition 36 2008 2270 2276
203. T. Yokooji, M. Kida, M. Mori, H. Akashi, N. Mori, S. Yoshihara, and T. Murakami Interaction of Rhei Rhizoma extract with cytochrome P450 3A and efflux transporters in rats Pharmazie 65 2010 367 374
204. S. Yu, Y. Yu, L. Liu, X. Wang, S. Lu, Y. Liang, X. Liu, L. Xie, and G. Wang Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved? Planta Medica 76 2010 876 881
205. X.Y. Yu, S.G. Lin, X. Chen, Z.W. Zhou, J. Liang, W. Duan, B. Chowbay, J.Y. Wen, E. Chan, J. Cao, C.G. Li, and S.F. Zhou Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier Current Drug Metabolism 8 2007 365 378
206. X.Y. Yu, S.G. Lin, Z.W. Zhou, X. Chen, J. Liang, P.Q. Liu, W. Duan, B. Chowbay, J.Y. Wen, C.G. Li, and S.F. Zhou Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge Current Drug Metabolism 8 2007 325 340
207. X.Y. Yu, Z.W. Zhou, S.G. Lin, X. Chen, X.Q. Yu, J. Liang, W. Duan, J.Y. Wen, X.T. Li, and S.F. Zhou Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza Xenobiotica 37 2007 375 415
208. D.M. Zhang, Z.W. He, X.D. Liu, Y. Li, L. Xie, G.J. Wang, and L. Liu In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier The Journal of Pharmacy and Pharmacology 59 2007 1733 1738
209. J. Zhang, M. Huang, S. Guan, H.C. Bi, Y. Pan, W. Duan, S.Y. Chan, X. Chen, Y.H. Hong, J.S. Bian, H.Y. Yang, and S. Zhou A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza The Journal of Pharmacology and Experimental Therapeutics 317 2006 1285 1294
210. J. Zhang, F. Zhou, X. Wu, Y. Gu, H. Ai, Y. Zheng, Y. Li, X. Zhang, G. Hao, J. Sun, Y. Peng, and G. Wang 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions Drug Metabolism and Disposition 38 2010 2179 2187
211. R. Zhang, J. Jie, Y. Zhou, Z. Cao, and W. Li Long-term effects of Panax ginseng on disposition of fexofenadine in rats in vivo The American Journal of Chinese Medicine 37 2009 657 667
212. D.C. Zhou, R. Zittoun, and J.P. Marie Homoharringtonine: an effective new natural product in cancer chemotherapy Bulletin du Cancer 82 1995 987 995
213. Z.W. Zhou, X. Chen, J. Liang, X.Y. Yu, J.Y. Wen, and S.F. Zhou Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier Drug Metabolism Letters 1 2007 205 217
214. A. Zhu, X. Wang, and Z. Guo Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent) Nuclear Medicine and Biology 28 2001 735 740
215. D.F. Zhu, X.P. Zhao, and Y.Y. Cheng Transport mechanism of danshensu across Caco-2 monolayer model Zhongguo Zhong Yao Za Zhi 31 2006 1517 1521 (article in Chinese)
216. S.S. Zou, R. Xu, and Q.Y. He Mechanism of Chinese herbal compound Zilongjin for antagonizing multi-drug resistance of tumor cells Zhongguo Zhong Xi Yi Jie He Za Zhi 30 2010 601 606 (article in Chinese)